BioAffinity Technologies, Inc. . announced Sheila Habib, MD, Director of Pulmonary Lung Nodule Clinic and the Lung Cancer Screening Program at the South Texas Veterans Health Care Systems' Audie L. Murphy Memorial Veterans Hospital, and David Hill, MD, National Board Member of the American Lung Association and assistant clinical professor of medicine at Yale University School of Medicine, have joined the Company's Scientific and Medical Advisory Board.
bioAffinity Technologies, Inc.
Equities
BIAF
US09076W1099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | +1.32% | -4.17% | +56.41% |
15/05 | BioAffinity Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
15/05 | Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $2.4M | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+56.41% | 26.81M | |
-6.76% | 11.98B | |
-5.68% | 8B | |
+8.91% | 5.85B | |
+28.87% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-60.92% | 2.62B | |
-6.99% | 2.33B | |
-8.85% | 1.78B |
- Stock Market
- Equities
- BIAF Stock
- News bioAffinity Technologies, Inc.
- Bioaffinity Technologies Announces Joining of Sheila Habib and David Hill to Scientific and Medical Advisory Board